Merck Scraps COVID Vaccines; Says It’s More Effective To Get The Virus And Recover
Shots generated an ‘inferior’ immune system response in comparison with natural infection
Vaccine manufacturer Merck has abandoned development of two coronavirus vaccines, saying that after extensive research it was concluded that the shots offered less protection than just contracting the virus itself and developing antibodies.
Chris Clor / Getty Images
The company announced that the shots V590 and V591 were ‘well tolerated’ by test patients, however they generated an ‘inferior’ immune system response in comparison with natural infection.
The company stated that instead it will focus on research into therapeutic drugs labeled as MK-7110 and MK-4482.
The drugs aim to protect patients from the damage of an overactive immune response to the virus.
“Interim results from a Phase 3 study showed a greater than 50 percent reduction in the risk of death or respiratory failure in patients hospitalized with moderate to severe COVID-19,” the company’s statement noted of the MK-7110 drug.
Merck is to receive around $356 million from the US government to fast-track production of the potential treatments under Operation Warp Speed.
Chief Marketing Officer Michael Nally recently told Bloomberg that Merck is aiming to produce some 20 million courses of the MK-4482 drug, an oral antiviral which patients will take twice a day for five days.
Meanwhile, in related news, German scientists have claimed that the UK Oxford/AstraZeneca vaccine is less than 8% effective in over 65s, prompting the vaccine developers to hit back, rubbishing the claims.
The German media published the claims, alleging it had been ‘confirmed’ by ‘multiple’ unnamed senior German government sources.
UK government ministers have suggested that the claim could be related to the ongoing dispute over delivery of the vaccine between the European Union and AstraZeneca.
The EU, which is yet to approve the vaccine, has threatened to block exports of shots to Britain, in a move that has been branded ‘spiteful’ by British government sources.
In an effort to make sure its member states get their ‘fair share’ of vaccines, the EU has also threatened to block the delivery of Pfizer vaccines to the UK, demanding that drug companies provide detailed information on when they plan to export Covid jabs to countries outside the bloc.
More from Summit News
(TLB) published this article by Steve Watson from Summit News with our sincere gratitude for the coverage and availability.
Header featured image/vaccine/gloved hands/NBC screen shot
Stay tuned to …
The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)
Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.
Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.